Isolating Artemisinin: From Extraction Methods to Antimalarial Research

In the 1960s, malaria continued to impose a heavy burden in Asia, while resistance in some Plasmodium falciparum parasites reduced the effectiveness of existing drugs. In 1967, China launched the antimalarial research effort later known as Project 523, bringing military, medical-research and local institutions together to find medicines. It included both synthetic compounds and screening active constituents from traditional medicines. The objective was a testable antimalarial effect, not efficacy assumed from a drug name or an ancient text.

In 1969, Tu Youyou joined and led the relevant research group at the Institute of Chinese Materia Medica of the Academy of Traditional Chinese Medicine in Beijing. The team collected historical prescriptions and folk experience, prepared extracts, and screened them in experimental animals infected with malaria parasites. This process turned documentary leads into comparable samples. Whether a medicinal plant merited further work depended on repeated test results, not merely on its past use against fever.

References: [1] [3]

Early sweet-wormwood extracts gave inconsistent results. In her recollections, Tu identified the description of soaking and squeezing juice in Ge Hong's Zhouhou Beiji Fang as an important inspiration. Traditional methods had not invariably involved prolonged boiling, prompting her to reconsider extraction temperature and operating conditions. The team subsequently altered solvents and separation steps, prepared extracts at lower temperatures and tested different fractions separately. The ancient text suggested a new question, while modern experiments determined which fraction was actually effective.

Obtaining a highly active extract in 1971 was a crucial advance, but did not yet amount to obtaining a pure drug. A mixture could contain active, inactive and adverse constituents, while geographic origin, harvesting time and processing methods could also change results. Animal screening therefore had to alternate repeatedly with chemical separation: each isolated fraction was checked for retained antimalarial activity, progressively narrowing the material to pursue.

References: [1] [3]

In 1972, the Institute of Chinese Materia Medica team isolated antimalarial crystals from sweet wormwood, later called artemisinin, or qinghaosu. The significance of this milestone was the further resolution of an effective extract into a chemical substance that could be weighed, analysed and compared. Crystals did not mean every chemical question was answered: confirming composition, structure and relationships to activity still required independent analysis and experimentation.

Research institutions in Shandong and Yunnan also studied sweet wormwood's active constituents and supplied samples. The Chinese Academy of Sciences' Shanghai Institute of Organic Chemistry and Institute of Biophysics, among others, participated in structural research. This collaboration gradually established a sesquiterpene lactone containing a peroxide structure, unlike the structures of commonly used antimalarials at the time. Isolation, structural confirmation and public publication occurred in different stages; later chemical understanding cannot all be attributed to 1972.

References: [1] [2] [3]

The candidate still had to cross the barriers of safety, formulation and efficacy in humans. Early research included self-administration by researchers and clinical observations in malaria-endemic areas. Patient studies in Hainan and elsewhere tested laboratory findings under conditions of actual infection. Clinical teams including those at Guangzhou College of Traditional Chinese Medicine and local collaborating institutions took part in subsequent work. Activity in animals justified further research but could not substitute directly for patient evidence.

In 1979, the coordinating group published a comprehensive report in the English-language Chinese Medical Journal, bringing together chemical, pharmacological and clinical research. It supported artemisinin's effects on blood-stage malaria parasites while also showing that clearing parasites from blood and preventing recrudescence were different problems. Clinical observations had to distinguish parasite species, formulations, treatment courses and follow-up results. The early case material was exploratory and should not be described as a large modern randomized trial that had already solved every treatment problem.

References: [1] [2]

Isolation of artemisinin enabled further preparation of dihydroartemisinin and other derivatives. Subsequent research addressed solubility, routes of administration and drug effects, gradually making the plant-derived candidate a basis for different formulations. Later still, treatment regimens combining it with other antimalarials formed a new phase of application. These results cannot be conflated with the effects of the initial extracts or a single crystalline compound.

The research's historical importance lay in both experiments and organization: ancient experience suggested subjects worth investigating, chemical and biological tests eliminated unreliable leads, and cooperation among institutions connected isolation, structure, formulation and clinical work. Calling artemisinin a gift from traditional knowledge to modern medicine does not mean that untested herbs can replace standardized drugs. Comparability and wider application became possible because the substance, dose, results and limitations at each step were progressively clarified.

References: [1] [3]